The Aflac Cancer and Blood Disorders Center of Children’s has been selected to be a member of the Children’s Oncology Group (COG) Phase I and Pilot Consortium.
COG is the world’s largest, cooperative cancer research entity with 240 member hospitals worldwide. COG hospitals treat 90 percent of children in the U.S. with cancer and conduct approximately 100 different collaborative research studies at a time leading to improvements in childhood cancer treatment.
The Aflac Cancer Center is now part of an elite group of only 21 centers nationwide and one of three in the Southeast to receive this prestigious designation allowing us access to the most promising agents as they are developed for children.
Over the past several years, many children have received innovative therapy treatments at the Aflac Cancer Center. This COG appointment will go even further allowing the majority of our patients to remain at home in Georgia to receive the most cutting edge treatments. This also allows us to become a referral center for patients outside of Georgia who might otherwise not have access to Phase I trials.